Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting

INTRODUCTION: Chemotherapy-induced nausea and vomiting (CINV) represents a significant burden on patients and healthcare systems. Despite the introduction of serotonin antagonists, many patients still experience CINV, particularly delayed symptoms occurring more than 24 hours after chemotherapy. Apr...

Descripción completa

Detalles Bibliográficos
Autor principal: Chrisp, Paul
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Place in Therapy Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012554/
https://www.ncbi.nlm.nih.gov/pubmed/21221195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012554/
https://www.ncbi.nlm.nih.gov/pubmed/21221195

Ejemplares similares